Search by Drug Name or NDC
NDC 70000-0421-01 Leader Effervescent Antacid and Pain Relief 1000; 325; 1916 mg/1; mg/1; mg/1 Details
Leader Effervescent Antacid and Pain Relief 1000; 325; 1916 mg/1; mg/1; mg/1
Leader Effervescent Antacid and Pain Relief is a ORAL TABLET, EFFERVESCENT in the HUMAN OTC DRUG category. It is labeled and distributed by Cardinal Health. The primary component is ANHYDROUS CITRIC ACID; ASPIRIN; SODIUM BICARBONATE.
Product Information
NDC | 70000-0421 |
---|---|
Product ID | 70000-0421_ef6c032d-7808-d552-e053-2a95a90a84dc |
Associated GPIs | 64109902110820 |
GCN Sequence Number | 059732 |
GCN Sequence Number Description | aspirin/sod bicarb/citric acid TABLET EFF 325-1916MG ORAL |
HIC3 | H3D |
HIC3 Description | ANALGESIC/ANTIPYRETICS, SALICYLATES |
GCN | 25515 |
HICL Sequence Number | 001801 |
HICL Sequence Number Description | ASPIRIN/SODIUM BICARBONATE/CITRIC ACID |
Brand/Generic | Generic |
Proprietary Name | Leader Effervescent Antacid and Pain Relief |
Proprietary Name Suffix | n/a |
Non-Proprietary Name | Aspirin, Citric Acid, Sodium Bicarbonate |
Product Type | HUMAN OTC DRUG |
Dosage Form | TABLET, EFFERVESCENT |
Route | ORAL |
Active Ingredient Strength | 1000; 325; 1916 |
Active Ingredient Units | mg/1; mg/1; mg/1 |
Substance Name | ANHYDROUS CITRIC ACID; ASPIRIN; SODIUM BICARBONATE |
Labeler Name | Cardinal Health |
Pharmaceutical Class | Acidifying Activity [MoA], Alkalinizing Activity [MoA], Anti-Inflammatory Agents, Non-Steroidal [CS], Anti-coagulant [EPC], Calcium Chelating Activity [MoA], Calculi Dissolution Agent [EPC], Cyclooxygenase Inhibitors [MoA], Decreased Coagulation Factor Ac |
DEA Schedule | n/a |
Marketing Category | OTC MONOGRAPH FINAL |
Application Number | part343 |
Listing Certified Through | n/a |
Package
NDC 70000-0421-01 (70000042101)
NDC Package Code | 70000-0421-1 |
---|---|
Billing NDC | 70000042101 |
Package | 18 POUCH in 1 CARTON (70000-0421-1) / 2 TABLET, EFFERVESCENT in 1 POUCH |
Marketing Start Date | 2019-04-10 |
NDC Exclude Flag | N |
Pricing Information | N/A |